# Paragonix Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/paragonix-technologies

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.paragonixtechnologies.com
- Total disclosed funding: $24M
- Latest round: Series B (Mar 3, 2023)
- Investors on record: 1

## About

Founded in 2010 by Lisa Anderson  (CEO) and others, and based in Massachusetts, US, Paragonix Technologies, Inc. operates as a manufacturer of medical devices used in the preservation and transportation of organs. In March 2023, new investor Signet Healthcare Partners led a USD 24 million Series B funding for Paragonix Technologies, Inc.

The company provides the LIVERguard System, LUNGguard Donor Lung Preservation System, and Paragonix SherpaPak®, which provide stable preservation methodologies to protect donor organs during the transfer between donor and recipient patients. Additionally, the company's devices work with its mobile app to provide transplant teams with real-time organ-tracking information and logistical monitoring. 

The company intends to use the March 2023 funding to increase its commercial footprint, enhance transplant technologies, and continue to expand its inventory and clinical service offerings.

## Funding rounds

- Series B, Mar 3, 2023, $24M — Signet Healthcare Partners

## Investors

- Signet Healthcare Partners (https://capitalatlas.ai/funds/signet-healthcare-partners) — Series B